Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects

Background: The metabolic syndrome (MS) is often accompanied by atherogenic dyslipidemia, which is characterized by elevated triglycerides (TG), reduced high‐density lipoprotein cholesterol (HDL‐C), and elevated numbers of small, dense low‐density lipoprotein(LDL) particles. Hypothesis: It was hypot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Main Authors: Davidson, Michael H., Bays, Harold E., Stein, Evan, Maki, Kevin C., Shalwitz, Robert A., Doyle, Ralph
Formato: Artigo
Idioma:Inglês
Publicado: Wiley Periodicals, Inc. 2006
Assuntos:
Clinical Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6653967/
https://ncbi.nlm.nih.gov/pubmed/16796078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960290609
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares